182 related articles for article (PubMed ID: 21619452)
1. Cyclic AMP-induced p53 destabilization is independent of EPAC in pre-B acute lymphoblastic leukemia cells in vitro.
Safa M; Kazemi A; Zaker F; Razmkhah F
J Recept Signal Transduct Res; 2011 Jun; 31(3):256-63. PubMed ID: 21619452
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory role of cAMP on doxorubicin-induced apoptosis in pre-B ALL cells through dephosphorylation of p53 serine residues.
Safa M; Kazemi A; Zand H; Azarkeivan A; Zaker F; Hayat P
Apoptosis; 2010 Feb; 15(2):196-203. PubMed ID: 19882354
[TBL] [Abstract][Full Text] [Related]
3. PI3K/AKT and Mdm2 activation are associated with inhibitory effect of cAMP increasing agents on DNA damage-induced cell death in human pre-B NALM-6 cells.
Ghorbani A; Jeddi-Tehrani M; Saidpour A; Safa M; Bayat AA; Zand H
Arch Biochem Biophys; 2015 Jan; 566():58-66. PubMed ID: 25524737
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow stroma-derived PGE2 protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death.
Naderi EH; Skah S; Ugland H; Myklebost O; Sandnes DL; Torgersen ML; Josefsen D; Ruud E; Naderi S; Blomhoff HK
Mol Cancer; 2015 Jan; 14(1):14. PubMed ID: 25623255
[TBL] [Abstract][Full Text] [Related]
5. Role of the exchange protein directly activated by cyclic adenosine 5'-monophosphate (Epac) pathway in regulating proglucagon gene expression in intestinal endocrine L cells.
Lotfi S; Li Z; Sun J; Zuo Y; Lam PP; Kang Y; Rahimi M; Islam D; Wang P; Gaisano HY; Jin T
Endocrinology; 2006 Aug; 147(8):3727-36. PubMed ID: 16644915
[TBL] [Abstract][Full Text] [Related]
6. Elevation of cyclic AMP causes an imbalance between NF-kappaB and p53 in NALM-6 cells treated by doxorubicin.
Safa M; Zand H; Mousavizadeh K; Kazemi A; Bakhshayesh M; Hayat P
FEBS Lett; 2010 Aug; 584(15):3492-8. PubMed ID: 20624391
[TBL] [Abstract][Full Text] [Related]
7. RITA enhances chemosensivity of pre-B ALL cells to doxorubicin by inducing p53-dependent apoptosis.
Kazemi A; Safa M; Shahbazi A
Hematology; 2011 Jul; 16(4):225-31. PubMed ID: 21756539
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase inhibitors control A172 human glioblastoma cell death through cAMP-mediated activation of protein kinase A and Epac1/Rap1 pathways.
Moon EY; Lee GH; Lee MS; Kim HM; Lee JW
Life Sci; 2012 Feb; 90(9-10):373-80. PubMed ID: 22227470
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of cell death in malignant vs normal B-cell precursors: implications for cAMP in development and treatment of BCP-ALL.
Naderi EH; Ugland HK; Diep PP; Josefsen D; Ruud E; Naderi S; Blomhoff HK
Blood; 2013 Mar; 121(10):1805-13. PubMed ID: 23299313
[TBL] [Abstract][Full Text] [Related]
10. cAMP Dose-dependently prevents palmitate-induced apoptosis by both protein kinase A- and cAMP-guanine nucleotide exchange factor-dependent pathways in beta-cells.
Kwon G; Pappan KL; Marshall CA; Schaffer JE; McDaniel ML
J Biol Chem; 2004 Mar; 279(10):8938-45. PubMed ID: 14688288
[TBL] [Abstract][Full Text] [Related]
11. Cyclic AMP-Induced p53 Destabilization is Independent of CREB in Pre-B Acute Lymphoblastic Leukemia Cells.
Manafi Shabestari R; Safa M; Banan M; Kazemi A
Int J Mol Cell Med; 2016; 5(4):220-228. PubMed ID: 28357198
[TBL] [Abstract][Full Text] [Related]
12. Activation of cAMP signaling inhibits DNA damage-induced apoptosis in BCP-ALL cells through abrogation of p53 accumulation.
Naderi EH; Findley HW; Ruud E; Blomhoff HK; Naderi S
Blood; 2009 Jul; 114(3):608-18. PubMed ID: 19451550
[TBL] [Abstract][Full Text] [Related]
13. cAMP inhibits migration, ruffling and paxillin accumulation in focal adhesions of pancreatic ductal adenocarcinoma cells: effects of PKA and EPAC.
Burdyga A; Conant A; Haynes L; Zhang J; Jalink K; Sutton R; Neoptolemos J; Costello E; Tepikin A
Biochim Biophys Acta; 2013 Dec; 1833(12):2664-2672. PubMed ID: 23797058
[TBL] [Abstract][Full Text] [Related]
14. The biphasic induction of p21 and p27 in breast cancer cells by modulators of cAMP is posttranscriptionally regulated and independent of the PKA pathway.
Rao S; Gray-Bablin J; Herliczek TW; Keyomarsi K
Exp Cell Res; 1999 Oct; 252(1):211-23. PubMed ID: 10502413
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of extracellular signal-regulated protein kinases (ERKs) 1 and 2 by cAMP and dissociation of ERK inhibition from anti-mitogenic effects in rabbit vascular smooth muscle cells.
Cospedal R; Lobo M; Zachary I
Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):407-14. PubMed ID: 10455028
[TBL] [Abstract][Full Text] [Related]
16. Cyclic adenosine 5'-monophosphate-stimulated neurotensin secretion is mediated through Rap1 downstream of both Epac and protein kinase A signaling pathways.
Li J; O'Connor KL; Cheng X; Mei FC; Uchida T; Townsend CM; Evers BM
Mol Endocrinol; 2007 Jan; 21(1):159-71. PubMed ID: 17068197
[TBL] [Abstract][Full Text] [Related]
17. p53-independent epigenetic repression of the p21(WAF1) gene in T-cell acute lymphoblastic leukemia.
Davies C; Hogarth LA; Dietrich PA; Bachmann PS; Mackenzie KL; Hall AG; Lock RB
J Biol Chem; 2011 Oct; 286(43):37639-50. PubMed ID: 21903579
[TBL] [Abstract][Full Text] [Related]
18. PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.
Zhou M; Gu L; Findley HW; Jiang R; Woods WG
Cancer Res; 2003 Oct; 63(19):6357-62. PubMed ID: 14559824
[TBL] [Abstract][Full Text] [Related]
19. Activation of cAMP signaling interferes with stress-induced p53 accumulation in ALL-derived cells by promoting the interaction between p53 and HDM2.
Naderi EH; Jochemsen AG; Blomhoff HK; Naderi S
Neoplasia; 2011 Jul; 13(7):653-63. PubMed ID: 21750659
[TBL] [Abstract][Full Text] [Related]
20. The cAMP signaling system inhibits the repair of γ-ray-induced DNA damage by promoting Epac1-mediated proteasomal degradation of XRCC1 protein in human lung cancer cells.
Cho EA; Juhnn YS
Biochem Biophys Res Commun; 2012 Jun; 422(2):256-62. PubMed ID: 22575451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
